SAMSUNG E&A

Reyon pharm Evergreen Project

The Chungju plant of Reyon Pharmaceutical is a pharmaceutical complex that produces state-of-the-art gene therapy products and synthetic drugs. We were awarded this project in an e (re-engineering), P, C + Validation format. This project was our first gene therapy medicine production facility project. Gene therapy product is the third-generation biomedicine following the second-generation biomedicine, the anti-body treatment medicine. The project signals our entry into the next-generation market that holds great growth potentials. We have secured a global competitive edge from building various second-generation biomedicine production facilities, such as Samsung Biologics Phase 1~3 Plants and Dong-A DM Bio Project. With Reyon Pharm Evergreen Project, we are committed to becomimg a leading company in the fast-growing cell and gene therapy medicine plant market.